Development of Post-Disaster Care Protocol for Pregnant Women and Evaluation of Its Effectiveness
Launched by SAKARYA UNIVERSITY · Jun 30, 2025
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a special care plan designed to help pregnant women who have experienced an earthquake. The goal is to see if this plan can improve their physical and mental health during a difficult time. The study is currently looking for women who are over 18 years old, pregnant, and able to read, write, and speak Turkish. Participants should not have severe depression, serious health problems, or high-risk pregnancies that need hospital care. They also need to be willing to take part in the study.
If you join the study, you can expect to receive care based on the new plan, and the researchers will check how it affects your well-being. This care aims to provide extra support during the stressful period after a disaster. It’s important to know that this study focuses only on women who meet the specific criteria and are comfortable communicating in Turkish. This helps the researchers understand how well the care plan works for pregnant women in earthquake-affected areas.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Over the age of 18,
- • Positive (+) pregnancy,
- • Able to read and write Turkish and speak and understand Turkish,
- • No mental or psychological disorder that would cause difficulty in expressing oneself,
- • Not receiving a score between 20-27 (severe depression) on HSA-9,
- • No chronic disease or high-risk pregnancy diagnosis requiring hospitalization and follow-up,
- • Volunteer to participate in the study
- Exclusion Criteria:
- • Under 18 years of age,
- • Foreign nationals who cannot read or write Turkish and are inadequate in speaking or understanding Turkish,
- • Those with any mental or psychological disorder/diagnosis,
- • Those who score between 20-27 (severe depression) on HSA-9,
- • Those with a chronic disease or a diagnosis of high-risk pregnancy requiring hospitalization and follow-up,
- • Those who do not agree to participate in the study
About Sakarya University
Sakarya University is a distinguished academic institution dedicated to advancing scientific research and innovation in healthcare. With a robust commitment to improving patient outcomes, the university actively sponsors clinical trials that explore novel therapeutic approaches and contribute to evidence-based medicine. Leveraging a multidisciplinary team of researchers, clinicians, and scholars, Sakarya University fosters a collaborative environment aimed at enhancing clinical practices and addressing pressing health challenges. Through these initiatives, the university not only enriches the academic landscape but also plays a pivotal role in translating research findings into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hatay, , Turkey
Patients applied
Trial Officials
Hatice Tambağ, Prof.Dr.
Study Director
Hatay Mustafa Kemal Üniversitesi
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported